SO
Sobi
Seneste kurs
463,20 SEK
22.7.2026
Seneste
515,00 SEK
+11.18%
Opside
3 mdr.
515,60 SEK
+11.31%
Opside
SOBI
3 mdr.+11,31%10 kursmål
6 mdr.+11,01%11 kursmål
1 år+9,85%12 kursmål
Max 26 kursmål
Deutsche BankSEBPareto SecuritiesHC WainwrightDanske BankDNB CarnegieBerenbergExane BNP ParibasBarclaysHandelsbanken
SundhedDrug Manufacturers—Specialty & Generic
Om selskabet
Swedish Orphan Biovitrum (Sobi) is a pharmaceutical company with two focus areas: haemophilia and rare diseases. Sobi is a merger of Swedish Orphan and Biovitrum. The company has its premises in Karolinska Institutet Science Park in Solna.
Wikipedia
Tre måneders konsensus
Konsensus
515,60 SEK
Opside
+11,31%
Seneste kurs463,20 SEK
Insiderhandel for Sobi
Ingen insiderhandler for den valgte periode.
